
Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity
Author(s) -
Osamu Kanauchi
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i7.1071
Subject(s) - butyrate , eubacterium , colitis , metabolite , inflammatory bowel disease , chemistry , microbiology and biotechnology , pharmacology , biology , food science , biochemistry , medicine , immunology , fermentation , bacteria , disease , genetics
To examine the effect of Eubacterium limosum (E. limosum) on colonic epithelial cell line in vitro, and to evaluate the effect of E. limosum on experimental colitis.